<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Sixteen children with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> as defined by the French-American-British co-operative group are presented </plain></SENT>
<SENT sid="1" pm="."><plain>The mean age was 10.5 (2.5 to 16) years, with a male predominance </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients belonged to the more aggressive subtypes of <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Seven patients presented with refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess blasts, six had <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts in transformation, and three had <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Cytogenetic analysis done in 7 of the 16 patients, revealed karyotype abnormalities involving chromosomes 7, 8 and 17 </plain></SENT>
<SENT sid="5" pm="."><plain>One patient with <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down's syndrome</z:e> had karyotype of 47, XY, +21 (major clone) and 46, XY (minor clone) </plain></SENT>
<SENT sid="6" pm="."><plain>Five of these patients evolved to <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>The mean duration of survival was 5.5 months </plain></SENT>
<SENT sid="8" pm="."><plain>Aggressive chemotherapy as a primary line of treatment induced remission in five out of six patients </plain></SENT>
<SENT sid="9" pm="."><plain>Predominance of aggressive types of <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> in children and their good but short-lived response to aggressive chemotherapy suggests the need for early bone marrow transplantation following chemotherapy </plain></SENT>
</text></document>